Encompass Health

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984, and is headquartered in Birmingham, AL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Encompass Health reports robust Q4 performance amidst operational challenges

Encompass Health delivered a strong performance in Q4 2022, showcasing financial growth, effective cost management, and strategic investments in hospital expansions.
While facing challenges such as administrative delays in de novo hospitals and fluctuations in case mix, the company remains focused on leveraging opportunities in market density and regulatory engagement.
With a clear focus on financial stability, growth opportunities, and strategic planning, Encompass Health aims to navigate industry challenges and drive future success.

Encompass Health reports strong Q1 earnings, eyes growth opportunities

Encompass Health (EHC) delivered a robust performance in Q1 2023, showcasing financial growth and operational efficiency.
While facing challenges in labor expenses and capacity constraints, the company remains focused on growth strategies and maintaining strong financial performance.
With raised guidance for 2023 and investments in technology, Encompass Health is poised to capitalize on opportunities for market expansion and improved patient outcomes.

Encompass Health reports robust Q2 earnings, eyes Medicare Advantage growth

Encompass Health's Q2 performance showcased strong revenue and EBITDA growth, driven by volume increases and cost efficiencies. The company's focus on strategic investments, capacity expansions, and optimizing Medicare Advantage revenues positions it well for future growth. Challenges in managing occupancy rates and potential Medicare payment structure changes require careful monitoring.

Encompass Health reports robust Q3 results amid labor cost reductions

Encompass Health's Q3 performance showcased strong revenue growth, operational efficiency, and effective cost management strategies.
The company's focus on key patient categories and capacity expansions position it well for future growth and market relevance.
While challenges like labor market dynamics persist, Encompass Health's strategic initiatives and financial outlook remain positive.

Encompass Health reports robust Q4 performance amidst growth investments

Encompass Health's Q4 2023 performance reflects strong financial growth, operational efficiency, and strategic investments, positioning the company for continued success.
While challenges such as labor inflation and margin sustainability persist, the company's focus on clinical innovation and readiness for regulatory changes bode well for future growth.
Opportunities in managed care, value-based arrangements, and expansion plans offer Encompass Health avenues for further development and enhancing its value proposition in the healthcare sector.

Encompass Health excels in Q1, poised for strategic growth

Encompass Health's Q1 performance reflects robust growth, operational resilience, and strategic foresight amidst industry challenges.
The company's focus on clinical excellence, capacity expansion, and financial discipline positions it for sustained success and market leadership.
While facing cybersecurity risks and regulatory uncertainties, Encompass Health's proactive approach and strong fundamentals mitigate potential challenges.
Encompass Health's upwardly revised guidance, strong patient volume trends, and investment in technology underscore its commitment to growth and innovation.

Encompass Health excels in Q3 2024, poised for growth

Encompass Health's Q3 2024 performance reflects robust revenue growth, operational efficiency, and strategic investments in capacity expansion.
The company's financial strength, resilience to operational challenges, and focus on innovation position it well for future growth opportunities.
While facing potential challenges in a dynamic healthcare landscape, Encompass Health has opportunities to drive growth through strategic initiatives and market expansion.
Overall, Encompass Health's strong performance, prudent financial management, and growth outlook make it a compelling player in the healthcare industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Although the revenue and EPS for Encompass Health (EHC) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Encompass Health (EHC) Reports Q4 Earnings: What Key Metrics Have to Say

BIRMINGHAM, Ala. , Feb. 7, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the fourth quarter ended December 31, 2023.

Encompass Health reports results for fourth quarter 2023 and issues 2024 guidance

BIRMINGHAM, Ala. , Feb. 5, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, today announced it has been named to Fortune's 'World's Most Admired Companies' list for 2024.

Encompass Health Corp. Named One of the World's Most Admired Companies in 2024 by Fortune

Encompass Health's (EHC) fourth-quarter results are likely to reflect pricing increases and growing volumes.

Encompass Health (EHC) to Post Q4 Earnings: What's in Store?

Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Encompass Health Corporation (EHC) Soars to 52-Week High, Time to Cash Out?

BIRMINGHAM, Ala. , Jan. 10, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its fourth quarter ended Dec. 31, 2023, after the market closes on Feb. 7, 2024.

Encompass Health announces date of 2023 fourth quarter earnings call

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.

Why You Should Invest in Encompass Health (EHC) Stock for Now

BIRMINGHAM, Ala. , Nov. 27, 2023 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced the appointment of Edward M.

Encompass Health appoints Ted Christie to its board of directors

Encompass Health (EHC) remains well-poised for growth on the back of an active expansion strategy and sufficient cash-generating abilities.

Here's Why Investors Should Hold Encompass Health (EHC) Now

The inpatient rehabilitation hospital's opening in Fitchburg, WI, was moved up from the initially scheduled first quarter of 2024.

Encompass Health (EHC) Opens Second Hospital in Wisconsin

Encompass Health (EHC) opens an inpatient rehabilitation hospital in Prosper to address the diversified needs of the greater Dallas area residents. It marks EHC's 160th nationwide facility.

Encompass Health (EHC) Opens Hospital to Boost Presence in Texas

Encompass Health Rehabilitation Hospital of Fitchburg, a 56-bed inpatient rehabilitation hospital, now open in Wisconsin

BIRMINGHAM, Ala. and PROSPER, Texas , Nov. 14, 2023 /PRNewswire/ -- Encompass Health (NYSE: EHC) announces the opening of Encompass Health Rehabilitation Hospital of Prosper , a 40-bed inpatient rehabilitation hospital located at 1231 Mahard Parkway.

Encompass Health Rehabilitation Hospital of Prosper, a 40-bed inpatient rehabilitation hospital, now open in Texas

Encompass Health (EHC) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Encompass Health (EHC) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Encompass Health (EHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Down -9.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Encompass Health (EHC)

Encompass Health Corporation (NYSE:EHC ) Q3 2023 Results Conference Call October 27, 2023 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President, CEO Doug Coltharp - CFO Conference Call Participants A.J. Rice - UBS Ann Hynes - Mizuho Securities Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Matt Larew - William Blair Kieran Ryan - Deutsche Bank Operator Good morning, everyone and welcome to Encompass Health's Third Quarter 2023 Earnings Conference Call.

Encompass Health Corporation (EHC) Q3 2023 Earnings Call Transcript

Encompass Health's (EHC) Q3 results benefit from an increase in patient volumes and net patient revenue per discharge. Management currently projects adjusted EPS to be within $3.41-$3.52 for 2023.

Encompass Health's (EHC) Q3 Earnings Beat on Discharge Growth

While the top- and bottom-line numbers for Encompass Health (EHC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Encompass Health (EHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Encompass Health (EHC) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to earnings of $0.67 per share a year ago.

Encompass Health (EHC) Surpasses Q3 Earnings and Revenue Estimates

Updates full-year guidance BIRMINGHAM, Ala. , Oct. 26, 2023 /PRNewswire/ -- - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the third quarter ended September 30, 2023.

Encompass Health reports results for third quarter 2023

Encompass Health's (EHC) Q3 results are likely to reflect improved inpatient volumes and bed additions, offset by higher operating expenses.

What's in the Cards for Encompass Health (EHC) in Q3 Earnings?

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth

BIRMINGHAM, Ala. , Oct. 6, 2023 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its third quarter ended Sept.

Encompass Health announces date of 2023 third quarter earnings call

Encompass Health (EHC) Up 41% in a Year: More Room for Growth?

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year.

News for Encompass Health Stock (EHC)